Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

  1. Gianni, L.
  2. Eiermann, W.
  3. Semiglazov, V.
  4. Manikhas, A.
  5. Lluch, A.
  6. Tjulandin, S.
  7. Zambetti, M.
  8. Vazquez, F.
  9. Byakhow, M.
  10. Lichinitser, M.
  11. Climent, M.A.
  12. Ciruelos, E.
  13. Ojeda, B.
  14. Mansutti, M.
  15. Bozhok, A.
  16. Baronio, R.
  17. Feyereislova, A.
  18. Barton, C.
  19. Valagussa, P.
  20. Baselga, J.
Aldizkaria:
The Lancet

ISSN: 0140-6736

Argitalpen urtea: 2010

Alea: 375

Zenbakia: 9712

Orrialdeak: 377-384

Mota: Artikulua

DOI: 10.1016/S0140-6736(09)61964-4 GOOGLE SCHOLAR